chr12-10166733-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002543.4(OLR1):āc.403A>Gā(p.Lys135Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000052 in 1,613,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002543.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OLR1 | NM_002543.4 | c.403A>G | p.Lys135Glu | missense_variant | 3/6 | ENST00000309539.8 | NP_002534.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OLR1 | ENST00000309539.8 | c.403A>G | p.Lys135Glu | missense_variant | 3/6 | 1 | NM_002543.4 | ENSP00000309124.3 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152052Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251402Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135872
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 727238
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152052Hom.: 0 Cov.: 31 AF XY: 0.0000943 AC XY: 7AN XY: 74262
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | The c.403A>G (p.K135E) alteration is located in exon 3 (coding exon 3) of the OLR1 gene. This alteration results from a A to G substitution at nucleotide position 403, causing the lysine (K) at amino acid position 135 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at